Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- MHLW Planning 10-Year Fund for Drug Discovery, Official Reveals at JPMA Meeting
January 24, 2025
- Nippon Shinyaku Gets FDA’s Rare Pediatric Disease Tag for DMD Drug
January 24, 2025
- Oral Flu Drug Prescriptions Hits Record High in Last Week of December: Survey
January 24, 2025
- Renascience to Open Branch Lab of Northwestern University Longevity Institute
January 23, 2025
- Shionogi Partners with Hitachi to Provide Digital Services
January 23, 2025
- Alimta Generics Broaden Label for Keytruda Combination in Japan
January 23, 2025
- Shionogi Wins Stockpile Pact for Xocova in Taiwan, NDA Accepted for Review
January 23, 2025
- Daiichi Sankyo Sets Up Advanced Drug-Discovery Lab in San Diego
January 22, 2025
- Sanofi CEO Warns Off-Cycle Price Cuts Will Dilute Attractiveness of Japan Market
January 22, 2025
- DyDo’s 1st Drug Firdapse for LEMS Hits Japan Market
January 22, 2025
- ITP Drug Tavalisse Approved in South Korea: Kissei
January 22, 2025
- Kobayashi Pharma to Revamp Management under New President
January 22, 2025
- Daito Bags Approval for Pain Medicine Pregabalin in China
January 22, 2025
- Lilly/Mitsubishi Tanabe to Push Proper Use of Zepbound
January 21, 2025
- Mitsubishi Chemical Says It’s Exploring All Options for Portfolio Reform
January 21, 2025
- Japanese PI Waiver Good News to Mega Pharma and Emerging Players Alike: Pfizer Execs
January 21, 2025
- Sumitomo, Janssen Tie Up for Xeplion Sales in Japan
January 21, 2025
- FDA Approves Daiichi’s New ADC Datroway for Breast Cancer
January 21, 2025
- Nxera’s 50 Billion Yen Global Sales Goal “Conservative Figure”: Japan Chief
January 20, 2025
- Cell and Gene Therapy Market Expected to Top US$20 Billion by 2028: IQVIA
January 20, 2025
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…